Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization

•E2 level/follicle (≥12 mm) on the trigger day could predict low oocyte retrieval events in patients with PCOS.•Low oocyte retrieval may not affect oocyte and embryo developmental potential.•Low oocyte retrieval may increase the risk of no embryo available for transfer. To investigate influencing fa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of obstetrics & gynecology and reproductive biology 2025-01, Vol.304, p.97-103
Hauptverfasser: Yin, Huiqun, Zhu, Jie, Wang, Cunli, Luan, Kang, Wu, Yan, Ni, Feng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 103
container_issue
container_start_page 97
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 304
creator Yin, Huiqun
Zhu, Jie
Wang, Cunli
Luan, Kang
Wu, Yan
Ni, Feng
description •E2 level/follicle (≥12 mm) on the trigger day could predict low oocyte retrieval events in patients with PCOS.•Low oocyte retrieval may not affect oocyte and embryo developmental potential.•Low oocyte retrieval may increase the risk of no embryo available for transfer. To investigate influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome (PCOS) undergoing in-vitro fertilization (IVF). In total, 720 patients with PCOS undergoing IVF were enrolled in this retrospective study from January 2017 to December 2022. The oocyte retrieval rate (ORR) was defined as the ratio of the number of oocytes retrieved to the number of follicles ≥ 12 mm in diameter on the trigger day. Using 1 standard deviation from the mean ORR as the boundary value, patients were divided into low and normal ORR groups. Patient characteristics, stimulation protocols, serum hormone levels, oocyte maturity, embryo developmental quality, and pregnancy outcomes of fresh transfer cycles were analysed. ORR ranged from 0.06 to 2.69, with a mean value of 1.02. Compared with the normal ORR group (ORR ≥ 0.65), patients in the low ORR group (ORR 
doi_str_mv 10.1016/j.ejogrb.2024.11.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3134065921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211524006353</els_id><sourcerecordid>3134065921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-51b681a2b5053ed92dfee11161be3c9b9a96432711f0fceb97fa36da2cd746743</originalsourceid><addsrcrecordid>eNp9kD1vFDEQhi0EIkfgHyDkkmYXj72fDRKKSIgUKQ3UltceHz7t2YftvWip88Px6ULKTDPN886reQj5CKwGBt2XXY27sI1TzRlvaoCa8eEV2cDQ86rv2uY12TDBoOIA7QV5l9KOlRFifEsuxNixgbNhQx5vvZ0X9Nr5LbVK5xATVd5QtBZ1TjRYOocHGoJeM9KIOTo8qpk6Tw8qO_SFeXD5Nz2EedVryk7TcFRxpWn1JoY90sUbjNtwanC-OrocA7UYs5vd33Ii-PfkjVVzwg9P-5L8uv7-8-pHdXd_c3v17a7SvIFctTB1Ayg-tawVaEZuLCIAdDCh0OM0qrFrBO8BLLMap7G3SnRGcW36pusbcUk-n-8eYvizYMpy75LGeVYew5KkANGwrh05FLQ5ozqGlCJaeYhuX96SwOTJv9zJs3958i8BZPFfYp-eGpZpj-Y59F94Ab6eASx_Hh1GmXSRqNG4WHxLE9zLDf8AdI2cSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134065921</pqid></control><display><type>article</type><title>Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yin, Huiqun ; Zhu, Jie ; Wang, Cunli ; Luan, Kang ; Wu, Yan ; Ni, Feng</creator><creatorcontrib>Yin, Huiqun ; Zhu, Jie ; Wang, Cunli ; Luan, Kang ; Wu, Yan ; Ni, Feng</creatorcontrib><description>•E2 level/follicle (≥12 mm) on the trigger day could predict low oocyte retrieval events in patients with PCOS.•Low oocyte retrieval may not affect oocyte and embryo developmental potential.•Low oocyte retrieval may increase the risk of no embryo available for transfer. To investigate influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome (PCOS) undergoing in-vitro fertilization (IVF). In total, 720 patients with PCOS undergoing IVF were enrolled in this retrospective study from January 2017 to December 2022. The oocyte retrieval rate (ORR) was defined as the ratio of the number of oocytes retrieved to the number of follicles ≥ 12 mm in diameter on the trigger day. Using 1 standard deviation from the mean ORR as the boundary value, patients were divided into low and normal ORR groups. Patient characteristics, stimulation protocols, serum hormone levels, oocyte maturity, embryo developmental quality, and pregnancy outcomes of fresh transfer cycles were analysed. ORR ranged from 0.06 to 2.69, with a mean value of 1.02. Compared with the normal ORR group (ORR ≥ 0.65), patients in the low ORR group (ORR &lt; 0.65) had a higher body mass index; higher antral follicle count (AFC); more days of gonadotrophin stimulation; and lower serum oestradiol (E2) level, lower progesterone level and lower E2 level/follicle (≥12 mm) on the trigger day. Multivariate logistic regression analysis showed AFC [adjusted odds ratio (aOR) 1.05, 95 % confidence interval (CI) 1.0120–1.0940], E2 level/follicle (≥12 mm) (aOR 0.99, 95 % CI 0.9888–0.9972) and progesterone level (aOR 0.41, 95 % CI 0.2402–0.6649) on the trigger day were significantly associated with low ORR. Receiver operator characteristic curve analyses revealed that serum E2 level/follicle (≥12 mm) had an area under the curve of 0.7036 (95 % CI 0.65–0.76; p &lt; 0.01). The cut-off value was 169.2 pg/ml, with sensitivity of 65 % and specificity of 65 %, for predicting low ORR. Low ORR was associated with fewer top-quality embryos and more cycles with no embryos available for transfer. The rates of metaphase II oocytes, top-quality embryos, clinical pregnancy and live birth did not differ between the two groups. Serum E2 level/follicle (≥12 mm) on the trigger day may be used as a predictive factor for low ORR in patients with PCOS. Low ORR may not affect oocyte and embryo developmental potential under appropriate ovarian stimulation management, but likely increases the risk of no embryos being available for transfer.</description><identifier>ISSN: 0301-2115</identifier><identifier>ISSN: 1872-7654</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2024.11.028</identifier><identifier>PMID: 39608208</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adult ; Estradiol - blood ; Female ; Fertilization in Vitro - methods ; Humans ; In-vitro fertilization ; Infertility, Female - blood ; Infertility, Female - etiology ; Infertility, Female - therapy ; Oocyte Retrieval ; Ovulation Induction - methods ; Polycystic ovary syndrome ; Polycystic Ovary Syndrome - blood ; Polycystic Ovary Syndrome - complications ; Polycystic Ovary Syndrome - therapy ; Pregnancy ; Pregnancy outcome ; Pregnancy Rate ; Retrospective Studies</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2025-01, Vol.304, p.97-103</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c241t-51b681a2b5053ed92dfee11161be3c9b9a96432711f0fceb97fa36da2cd746743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0301211524006353$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39608208$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yin, Huiqun</creatorcontrib><creatorcontrib>Zhu, Jie</creatorcontrib><creatorcontrib>Wang, Cunli</creatorcontrib><creatorcontrib>Luan, Kang</creatorcontrib><creatorcontrib>Wu, Yan</creatorcontrib><creatorcontrib>Ni, Feng</creatorcontrib><title>Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>•E2 level/follicle (≥12 mm) on the trigger day could predict low oocyte retrieval events in patients with PCOS.•Low oocyte retrieval may not affect oocyte and embryo developmental potential.•Low oocyte retrieval may increase the risk of no embryo available for transfer. To investigate influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome (PCOS) undergoing in-vitro fertilization (IVF). In total, 720 patients with PCOS undergoing IVF were enrolled in this retrospective study from January 2017 to December 2022. The oocyte retrieval rate (ORR) was defined as the ratio of the number of oocytes retrieved to the number of follicles ≥ 12 mm in diameter on the trigger day. Using 1 standard deviation from the mean ORR as the boundary value, patients were divided into low and normal ORR groups. Patient characteristics, stimulation protocols, serum hormone levels, oocyte maturity, embryo developmental quality, and pregnancy outcomes of fresh transfer cycles were analysed. ORR ranged from 0.06 to 2.69, with a mean value of 1.02. Compared with the normal ORR group (ORR ≥ 0.65), patients in the low ORR group (ORR &lt; 0.65) had a higher body mass index; higher antral follicle count (AFC); more days of gonadotrophin stimulation; and lower serum oestradiol (E2) level, lower progesterone level and lower E2 level/follicle (≥12 mm) on the trigger day. Multivariate logistic regression analysis showed AFC [adjusted odds ratio (aOR) 1.05, 95 % confidence interval (CI) 1.0120–1.0940], E2 level/follicle (≥12 mm) (aOR 0.99, 95 % CI 0.9888–0.9972) and progesterone level (aOR 0.41, 95 % CI 0.2402–0.6649) on the trigger day were significantly associated with low ORR. Receiver operator characteristic curve analyses revealed that serum E2 level/follicle (≥12 mm) had an area under the curve of 0.7036 (95 % CI 0.65–0.76; p &lt; 0.01). The cut-off value was 169.2 pg/ml, with sensitivity of 65 % and specificity of 65 %, for predicting low ORR. Low ORR was associated with fewer top-quality embryos and more cycles with no embryos available for transfer. The rates of metaphase II oocytes, top-quality embryos, clinical pregnancy and live birth did not differ between the two groups. Serum E2 level/follicle (≥12 mm) on the trigger day may be used as a predictive factor for low ORR in patients with PCOS. Low ORR may not affect oocyte and embryo developmental potential under appropriate ovarian stimulation management, but likely increases the risk of no embryos being available for transfer.</description><subject>Adult</subject><subject>Estradiol - blood</subject><subject>Female</subject><subject>Fertilization in Vitro - methods</subject><subject>Humans</subject><subject>In-vitro fertilization</subject><subject>Infertility, Female - blood</subject><subject>Infertility, Female - etiology</subject><subject>Infertility, Female - therapy</subject><subject>Oocyte Retrieval</subject><subject>Ovulation Induction - methods</subject><subject>Polycystic ovary syndrome</subject><subject>Polycystic Ovary Syndrome - blood</subject><subject>Polycystic Ovary Syndrome - complications</subject><subject>Polycystic Ovary Syndrome - therapy</subject><subject>Pregnancy</subject><subject>Pregnancy outcome</subject><subject>Pregnancy Rate</subject><subject>Retrospective Studies</subject><issn>0301-2115</issn><issn>1872-7654</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1vFDEQhi0EIkfgHyDkkmYXj72fDRKKSIgUKQ3UltceHz7t2YftvWip88Px6ULKTDPN886reQj5CKwGBt2XXY27sI1TzRlvaoCa8eEV2cDQ86rv2uY12TDBoOIA7QV5l9KOlRFifEsuxNixgbNhQx5vvZ0X9Nr5LbVK5xATVd5QtBZ1TjRYOocHGoJeM9KIOTo8qpk6Tw8qO_SFeXD5Nz2EedVryk7TcFRxpWn1JoY90sUbjNtwanC-OrocA7UYs5vd33Ii-PfkjVVzwg9P-5L8uv7-8-pHdXd_c3v17a7SvIFctTB1Ayg-tawVaEZuLCIAdDCh0OM0qrFrBO8BLLMap7G3SnRGcW36pusbcUk-n-8eYvizYMpy75LGeVYew5KkANGwrh05FLQ5ozqGlCJaeYhuX96SwOTJv9zJs3958i8BZPFfYp-eGpZpj-Y59F94Ab6eASx_Hh1GmXSRqNG4WHxLE9zLDf8AdI2cSw</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Yin, Huiqun</creator><creator>Zhu, Jie</creator><creator>Wang, Cunli</creator><creator>Luan, Kang</creator><creator>Wu, Yan</creator><creator>Ni, Feng</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202501</creationdate><title>Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization</title><author>Yin, Huiqun ; Zhu, Jie ; Wang, Cunli ; Luan, Kang ; Wu, Yan ; Ni, Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-51b681a2b5053ed92dfee11161be3c9b9a96432711f0fceb97fa36da2cd746743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adult</topic><topic>Estradiol - blood</topic><topic>Female</topic><topic>Fertilization in Vitro - methods</topic><topic>Humans</topic><topic>In-vitro fertilization</topic><topic>Infertility, Female - blood</topic><topic>Infertility, Female - etiology</topic><topic>Infertility, Female - therapy</topic><topic>Oocyte Retrieval</topic><topic>Ovulation Induction - methods</topic><topic>Polycystic ovary syndrome</topic><topic>Polycystic Ovary Syndrome - blood</topic><topic>Polycystic Ovary Syndrome - complications</topic><topic>Polycystic Ovary Syndrome - therapy</topic><topic>Pregnancy</topic><topic>Pregnancy outcome</topic><topic>Pregnancy Rate</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yin, Huiqun</creatorcontrib><creatorcontrib>Zhu, Jie</creatorcontrib><creatorcontrib>Wang, Cunli</creatorcontrib><creatorcontrib>Luan, Kang</creatorcontrib><creatorcontrib>Wu, Yan</creatorcontrib><creatorcontrib>Ni, Feng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yin, Huiqun</au><au>Zhu, Jie</au><au>Wang, Cunli</au><au>Luan, Kang</au><au>Wu, Yan</au><au>Ni, Feng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2025-01</date><risdate>2025</risdate><volume>304</volume><spage>97</spage><epage>103</epage><pages>97-103</pages><issn>0301-2115</issn><issn>1872-7654</issn><eissn>1872-7654</eissn><abstract>•E2 level/follicle (≥12 mm) on the trigger day could predict low oocyte retrieval events in patients with PCOS.•Low oocyte retrieval may not affect oocyte and embryo developmental potential.•Low oocyte retrieval may increase the risk of no embryo available for transfer. To investigate influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome (PCOS) undergoing in-vitro fertilization (IVF). In total, 720 patients with PCOS undergoing IVF were enrolled in this retrospective study from January 2017 to December 2022. The oocyte retrieval rate (ORR) was defined as the ratio of the number of oocytes retrieved to the number of follicles ≥ 12 mm in diameter on the trigger day. Using 1 standard deviation from the mean ORR as the boundary value, patients were divided into low and normal ORR groups. Patient characteristics, stimulation protocols, serum hormone levels, oocyte maturity, embryo developmental quality, and pregnancy outcomes of fresh transfer cycles were analysed. ORR ranged from 0.06 to 2.69, with a mean value of 1.02. Compared with the normal ORR group (ORR ≥ 0.65), patients in the low ORR group (ORR &lt; 0.65) had a higher body mass index; higher antral follicle count (AFC); more days of gonadotrophin stimulation; and lower serum oestradiol (E2) level, lower progesterone level and lower E2 level/follicle (≥12 mm) on the trigger day. Multivariate logistic regression analysis showed AFC [adjusted odds ratio (aOR) 1.05, 95 % confidence interval (CI) 1.0120–1.0940], E2 level/follicle (≥12 mm) (aOR 0.99, 95 % CI 0.9888–0.9972) and progesterone level (aOR 0.41, 95 % CI 0.2402–0.6649) on the trigger day were significantly associated with low ORR. Receiver operator characteristic curve analyses revealed that serum E2 level/follicle (≥12 mm) had an area under the curve of 0.7036 (95 % CI 0.65–0.76; p &lt; 0.01). The cut-off value was 169.2 pg/ml, with sensitivity of 65 % and specificity of 65 %, for predicting low ORR. Low ORR was associated with fewer top-quality embryos and more cycles with no embryos available for transfer. The rates of metaphase II oocytes, top-quality embryos, clinical pregnancy and live birth did not differ between the two groups. Serum E2 level/follicle (≥12 mm) on the trigger day may be used as a predictive factor for low ORR in patients with PCOS. Low ORR may not affect oocyte and embryo developmental potential under appropriate ovarian stimulation management, but likely increases the risk of no embryos being available for transfer.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>39608208</pmid><doi>10.1016/j.ejogrb.2024.11.028</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2025-01, Vol.304, p.97-103
issn 0301-2115
1872-7654
1872-7654
language eng
recordid cdi_proquest_miscellaneous_3134065921
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Estradiol - blood
Female
Fertilization in Vitro - methods
Humans
In-vitro fertilization
Infertility, Female - blood
Infertility, Female - etiology
Infertility, Female - therapy
Oocyte Retrieval
Ovulation Induction - methods
Polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - complications
Polycystic Ovary Syndrome - therapy
Pregnancy
Pregnancy outcome
Pregnancy Rate
Retrospective Studies
title Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A43%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influencing%20factors%20and%20effects%20of%20low%20oocyte%20retrieval%20in%20patients%20with%20polycystic%20ovary%20syndrome%20undergoing%20in-vitro%20fertilization&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Yin,%20Huiqun&rft.date=2025-01&rft.volume=304&rft.spage=97&rft.epage=103&rft.pages=97-103&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2024.11.028&rft_dat=%3Cproquest_cross%3E3134065921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134065921&rft_id=info:pmid/39608208&rft_els_id=S0301211524006353&rfr_iscdi=true